Poland – Various medicinal products – Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba.

Opportunity description

A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form - Packages Nos. 1–26. Package No. 1: Heparins, Package No. 2: Parenteral nutrition products, Package No. 3: Infusion fluids, Package No. 4: Various medicines 1, Package No. 5: Various medicines 2, Package No. 6: Various medicines 3, Package No. 7: Albumins/Immunoglobulins, Package No. 8: Lorazepam, Package No. 9: Human anti-D immunoglobulin [1], Package No. 10: Human anti-D immunoglobulin [2], Package No. 11: Nutrition products for infants, children and adults, Package No. 12: Various medicines 4, Package No. 13: Various medicines 5, Package No. 14: Various medicines 6, Package No. 15: Various medicines 7, Package No. 16: Various medicines 8, Package No. 17: Enteral nutrition products, Package No. 18: Various medicines 9, Package No. 19: Paliperidone, Package No. 20: Omeprazole/Pantoprazole, Package No. 21: Various medicines 10, Package No. 22: Various medicines 11, Package No. 23: Various medicines 12, Package No. 24: Propofol +EDTA, Package No. 25: Propofol, Package No. 26: Renal therapy products. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2, due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the possibility of changing the quantity of the ordered product within the quantities specified in the individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract are specified in the Draft contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to the medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In that item, the appropriate trade name and the product's EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority defined the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterizes products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favored or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Public Procurement Law, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall mean a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, boundary parameters. The term “parameters” means functionality, intended use, color scheme, structure, materials, shape, size, safety, strength, etc. h) In connection with the above, the Contracting Authority permits materials with different trademarks, patents or origin to be offered, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or in the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract were included in the calculation of the tender price and for performance of the contract. The Contracting Authority permits partial tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages is subject to subdivision). Articles classified as a medicinal product – within the meaning of the Act of 06 September 2001, Pharmaceutical Law (Journal of Laws of 2026, item 612, as amended) – must be authorized for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the relevant documents (if the law imposes an obligation to possess such documents). Medical articles classified as a medical device must possess documents authorizing them for marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law imposes an obligation to possess such documents). The contract performance period shall be from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever event occurs first. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 8: Lorazepam. Number of assortment items: 2. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2, due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the possibility of changing the quantity of the ordered product within the quantities specified in the individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract are specified in the Draft contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to the medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In that item, the appropriate trade name and the product's EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority defined the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterizes products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favored or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Public Procurement Law, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall mean a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, boundary parameters. The term “parameters” means functionality, intended use, color scheme, structure, materials, shape, size, safety, strength, etc. h) In connection with the above, the Contracting Authority permits materials with different trademarks, patents or origin to be offered, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or in the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract were included in the calculation of the tender price and for performance of the contract. III. A) Articles classified as a medicinal product – within the meaning of the Act of 06 September 2001, Pharmaceutical Law (Journal of Laws of 2026, item 612, as amended) – must be authorized for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the relevant documents (if the law imposes an obligation to possess such documents). B) Medical articles classified as a medical device must possess documents authorizing them for marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law imposes an obligation to possess such documents). IV. The contract performance period shall be from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever event occurs first. The indication of the end date for the supplies is justified by an objective reason: supplies will be made successively; the contract end date was specified in order to maintain continuity of supply; ending contracts on the same date for a given type of assortment is intended to maintain continuity of those contracts and also enables timely performance of the Contracting Authority's tasks. V. The Contracting Authority permits partial tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages is subject to subdivision). VI. The Contracting Authority permits amendment of the concluded contract during its performance in the cases specified in the Draft contract - Annex No. 4 to the SWZ. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 10: Human anti-D immunoglobulin [2]. Number of assortment items: 1. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2, due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the possibility of changing the quantity of the ordered product within the quantities specified in the individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract are specified in the Draft contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to the medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In that item, the appropriate trade name and the product's EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority defined the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterizes products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favored or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Public Procurement Law, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall mean a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, boundary parameters. The term “parameters” means functionality, intended use, color scheme, structure, materials, shape, size, safety, strength, etc. h) In connection with the above, the Contracting Authority permits materials with different trademarks, patents or origin to be offered, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or in the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract were included in the calculation of the tender price and for performance of the contract. III. A) Articles classified as a medicinal product – within the meaning of the Act of 06 September 2001, Pharmaceutical Law (Journal of Laws of 2026, item 612, as amended) – must be authorized for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the relevant documents (if the law imposes an obligation to possess such documents). B) Medical articles classified as a medical device must possess documents authorizing them for marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law imposes an obligation to possess such documents). IV. The contract performance period shall be from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever event occurs first. The indication of the end date for the supplies is justified by an objective reason: supplies will be made successively; the contract end date was specified in order to maintain continuity of supply; ending contracts on the same date for a given type of assortment is intended to maintain continuity of those contracts and also enables timely performance of the Contracting Authority's tasks. V. The Contracting Authority permits partial tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages is subject to subdivision). VI. The Contracting Authority permits amendment of the concluded contract during its performance in the cases specified in the Draft contract - Annex No. 4 to the SWZ. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 11: Nutrition products for infants, children and adults. Number of assortment items: 20. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2, due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the possibility of changing the quantity of the ordered product within the quantities specified in the individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract are specified in the Draft contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to the medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In that item, the appropriate trade name and the product's EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority defined the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterizes products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favored or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Public Procurement Law, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall mean a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, boundary parameters. The term “parameters” means functionality, intended use, color scheme, structure, materials, shape, size, safety, strength, etc. h) In connection with the above, the Contracting Authority permits materials with different trademarks, patents or origin to be offered, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or in the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract were included in the calculation of the tender price and for performance of the contract. III. A) Articles classified as a medicinal product – within the meaning of the Act of 06 September 2001, Pharmaceutical Law (Journal of Laws of 2026, item 612, as amended) – must be authorized for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the relevant documents (if the law imposes an obligation to possess such documents). B) Medical articles classified as a medical device must possess documents authorizing them for marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law imposes an obligation to possess such documents). IV. The contract performance period shall be from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever event occurs first. The indication of the end date for the supplies is justified by an objective reason: supplies will be made successively; the contract end date was specified in order to maintain continuity of supply; ending contracts on the same date for a given type of assortment is intended to maintain continuity of those contracts and also enables timely performance of the Contracting Authority's tasks. V. The Contracting Authority permits partial tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages is subject to subdivision). VI. The Contracting Authority permits amendment of the concluded contract during its performance in the cases specified in the Draft contract - Annex No. 4 to the SWZ. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 12: Various medicines 4. Number of assortment items: 2. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2, due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the possibility of changing the quantity of the ordered product within the quantities specified in the individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract are specified in the Draft contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to the medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In that item, the appropriate trade name and the product's EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority defined the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterizes products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favored or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Public Procurement Law, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall mean a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, boundary parameters. The term “parameters” means functionality, intended use, color scheme, structure, materials, shape, size, safety, strength, etc. h) In connection with the above, the Contracting Authority permits materials with different trademarks, patents or origin to be offered, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or in the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract were included in the calculation of the tender price and for performance of the contract. III. A) Articles classified as a medicinal product – within the meaning of the Act of 06 September 2001, Pharmaceutical Law (Journal of Laws of 2026, item 612, as amended) – must be authorized for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the relevant documents (if the law imposes an obligation to possess such documents). B) Medical articles classified as a medical device must possess documents authorizing them for marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law imposes an obligation to possess such documents). IV. The contract performance period shall be from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever event occurs first. The indication of the end date for the supplies is justified by an objective reason: supplies will be made successively; the contract end date was specified in order to maintain continuity of supply; ending contracts on the same date for a given type of assortment is intended to maintain continuity of those contracts and also enables timely performance of the Contracting Authority's tasks. V. The Contracting Authority permits partial tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages is subject to subdivision). VI. The Contracting Authority permits amendment of the concluded contract during its performance in the cases specified in the Draft contract - Annex No. 4 to the SWZ. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 13: Various medicines 5. Number of assortment items: 8. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2, due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the possibility of changing the quantity of the ordered product within the quantities specified in the individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract are specified in the Draft contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to the medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In that item, the appropriate trade name and the product's EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority defined the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterizes products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favored or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Public Procurement Law, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall mean a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, boundary parameters. The term “parameters” means functionality, intended use, color scheme, structure, materials, shape, size, safety, strength, etc. h) In connection with the above, the Contracting Authority permits materials with different trademarks, patents or origin to be offered, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or in the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract were included in the calculation of the tender price and for performance of the contract. III. A) Articles classified as a medicinal product – within the meaning of the Act of 06 September 2001, Pharmaceutical Law (Journal of Laws of 2026, item 612, as amended) – must be authorized for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the relevant documents (if the law imposes an obligation to possess such documents). B) Medical articles classified as a medical device must possess documents authorizing them for marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law imposes an obligation to possess such documents). IV. The contract performance period shall be from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever event occurs first. The indication of the end date for the supplies is justified by an objective reason: supplies will be made successively; the contract end date was specified in order to maintain continuity of supply; ending contracts on the same date for a given type of assortment is intended to maintain continuity of those contracts and also enables timely performance of the Contracting Authority's tasks. V. The Contracting Authority permits partial tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages is subject to subdivision). VI. The Contracting Authority permits amendment of the concluded contract during its performance in the cases specified in the Draft contract - Annex No. 4 to the SWZ. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 15: Various medicines 7. Number of assortment items: 642. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2, due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the possibility of changing the quantity of the ordered product within the quantities specified in the individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract are specified in the Draft contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to the medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In that item, the appropriate trade name and the product's EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority defined the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterizes products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favored or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Public Procurement Law, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall mean a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, boundary parameters. The term “parameters” means functionality, intended use, color scheme, structure, materials, shape, size, safety, strength, etc. h) In connection with the above, the Contracting Authority permits materials with different trademarks, patents or origin to be offered, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or in the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract were included in the calculation of the tender price and for performance of the contract. III. A) Articles classified as a medicinal product – within the meaning of the Act of 06 September 2001, Pharmaceutical Law (Journal of Laws of 2026, item 612, as amended) – must be authorized for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the relevant documents (if the law imposes an obligation to possess such documents). B) Medical articles classified as a medical device must possess documents authorizing them for marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law imposes an obligation to possess such documents). IV. The contract performance period shall be from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever event occurs first. The indication of the end date for the supplies is justified by an objective reason: supplies will be made successively; the contract end date was specified in order to maintain continuity of supply; ending contracts on the same date for a given type of assortment is intended to maintain continuity of those contracts and also enables timely performance of the Contracting Authority's tasks. V. The Contracting Authority permits partial tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages is subject to subdivision). VI. The Contracting Authority permits amendment of the concluded contract during its performance in the cases specified in the Draft contract - Annex No. 4 to the SWZ. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 18: Various medicines 9. Number of assortment items: 8. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2, due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the possibility of changing the quantity of the ordered product within the quantities specified in the individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract are specified in the Draft contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to the medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In that item, the appropriate trade name and the product's EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority defined the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterizes products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favored or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Public Procurement Law, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall mean a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, boundary parameters. The term “parameters” means functionality, intended use, color scheme, structure, materials, shape, size, safety, strength, etc. h) In connection with the above, the Contracting Authority permits materials with different trademarks, patents or origin to be offered, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or in the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract were included in the calculation of the tender price and for performance of the contract. III. A) Articles classified as a medicinal product – within the meaning of the Act of 06 September 2001, Pharmaceutical Law (Journal of Laws of 2026, item 612, as amended) – must be authorized for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the relevant documents (if the law imposes an obligation to possess such documents). B) Medical articles classified as a medical device must possess documents authorizing them for marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law imposes an obligation to possess such documents). IV. The contract performance period shall be from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever event occurs first. The indication of the end date for the supplies is justified by an objective reason: supplies will be made successively; the contract end date was specified in order to maintain continuity of supply; ending contracts on the same date for a given type of assortment is intended to maintain continuity of those contracts and also enables timely performance of the Contracting Authority's tasks. V. The Contracting Authority permits partial tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages is subject to subdivision). VI. The Contracting Authority permits amendment of the concluded contract during its performance in the cases specified in the Draft contract - Annex No. 4 to the SWZ. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 19: Paliperidone. Number of assortment items: 3. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2, due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the possibility of changing the quantity of the ordered product within the quantities specified in the individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract are specified in the Draft contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to the medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In that item, the appropriate trade name and the product's EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority defined the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterizes products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favored or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Public Procurement Law, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall mean a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, boundary parameters. The term “parameters” means functionality, intended use, color scheme, structure, materials, shape, size, safety, strength, etc. h) In connection with the above, the Contracting Authority permits materials with different trademarks, patents or origin to be offered, but not with properties and functionality different from those specified in the SWZ. i) Whenever a standard is indicated in this SWZ or in the annexes to the SWZ, it shall be assumed that the phrase “or equivalent” has been used in relation to it. j) If the Contractor does not submit documents in its tender concerning the use of other materials and equipment, this shall be understood to mean that the materials and equipment proposed in the description of the subject matter of the contract were included in the calculation of the tender price and for performance of the contract. III. A) Articles classified as a medicinal product – within the meaning of the Act of 06 September 2001, Pharmaceutical Law (Journal of Laws of 2026, item 612, as amended) – must be authorized for marketing in the territory of the Republic of Poland in accordance with the provisions of that Act and possess the relevant documents (if the law imposes an obligation to possess such documents). B) Medical articles classified as a medical device must possess documents authorizing them for marketing and use in accordance with the Act of 07 April 2022 on medical devices (Journal of Laws of 2024, item 1620), i.e. CE certificates, declarations of conformity, registration certificates – to the extent appropriate to the procedure in question (if the law imposes an obligation to possess such documents). IV. The contract performance period shall be from the effective date of the contract ……………… to 31.07.2027 or until the quantities of the assortment specified in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form – have been used, whichever event occurs first. The indication of the end date for the supplies is justified by an objective reason: supplies will be made successively; the contract end date was specified in order to maintain continuity of supply; ending contracts on the same date for a given type of assortment is intended to maintain continuity of those contracts and also enables timely performance of the Contracting Authority's tasks. V. The Contracting Authority permits partial tenders for all parts of the contract, divided into individual Packages from 1 to 26 (none of the Packages is subject to subdivision). VI. The Contracting Authority permits amendment of the concluded contract during its performance in the cases specified in the Draft contract - Annex No. 4 to the SWZ. I. Supply of medicinal products, pharmaceutical products, parenteral nutrition products and renal therapy fluids for SPZZOZ in Nowa Dęba. A detailed description and scope of the subject matter of the contract is contained in Annex No. 2 to the SWZ – Description of the subject matter of the contract - Assortment and price form, Package No. 21: Various medicines 10. Number of assortment items: 8. The quantities indicated in the Description of the subject matter of the contract - Assortment and price form, Annex No. 2 to the SWZ – are indicative quantities adopted for the purpose of comparing tenders and selecting the most advantageous tender. The Contracting Authority reserves the right to purchase a smaller quantity of the subject matter of the contract than that specified in Annex No. 2, due to the impossibility of predicting the full demand for the subject matter of the contract covered by this SWZ. The Contracting Authority reserves the possibility of changing the quantity of the ordered product within the quantities specified in the individual items of a given part; changes may concern a decrease or increase in quantity within +/- 30%, provided that the total value of the given part (package) is not exceeded. The remaining conditions concerning performance of the contract are specified in the Draft contract – Annex No. 4 to the SWZ and the other annexes to the SWZ. II. Information on equivalent solutions: a) The Contracting Authority does not limit the subject matter of the contract to the medicines listed by name. The Contracting Authority permits the submission of equivalent tenders – equivalent medicines/preparations, i.e. those having the same composition, dose and pharmaceutical form. In that item, the appropriate trade name and the product's EAN code (if it has one) must then be provided. b) Trade name – if a trade name of a product/company/goods appears in any annex to the SWZ, this means that the Contracting Authority was unable to define and describe the subject matter of the contract using sufficiently precise data, and it serves only to specify the desired standard of performance of the supply; c) If, in the description of the subject matter of the contract (annexes to the SWZ), the Contracting Authority defined the subject matter of the contract by indicating trademarks, patents or origin, source or a particular process that characterizes products or services supplied by a specific Contractor, where this could lead to certain Contractors or products being favored or eliminated, it permits the submission of equivalent tenders. d) In situations where the Contracting Authority describes the subject matter of the contract by reference to standards, European technical assessments, approvals, technical specifications and technical reference systems referred to in Article 101(1)(2) and (3) of the Public Procurement Law, it permits solutions equivalent to those described. e) The above specification of the subject matter of the contract is solely auxiliary in the preparation of the tender and is intended to indicate the expected standards regarding the minimum technical parameters of the expected materials and equipment. f) An equivalent tender shall mean a tender with technical, strength, quality and performance parameters no worse than the description indicated by the Contracting Authority in the description of the subject matter of the contract. g) The parameters indicated by the Contracting Authority are minimum, boundary parameters. The term “parameters” means functionality, intended use, color scheme, structure, materials, shape, size, safety, strength, etc. h) In connection with the above, the Contracting Authority permits materials with different trademarks, patents or origin to be offered, but not with properties and functionality different from those s